Vascular endothelial growth factors and angiopoietins in presentations and prognosis of papillary thyroid carcinoma

Journal of Surgical Oncology

Volumn 103, Issue 5, 2011, Pages 395-399

  Hsueh, Chuen ^a   Lin, Jen Der ^a   Wu, I Chin ^a   Chao, Tzu Chieh ^a   Yu, Jau Song ^a   Liou, Miaw Jene ^a   Yeh, Chi Ju ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Angiogenesis; Cancer recurrence; Immunochemical staining; Thyroglobulin; Total thyroidectomy

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; VASCULOTROPIN;

ADULT; ARTICLE; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

ADULT; ANGIOPOIETIN-1; ANGIOPOIETIN-2; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, TIE-2; SURVIVAL RATE; THYROID GLAND; THYROID NEOPLASMS; THYROIDECTOMY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79952603698     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21844     Document Type: Article

References (28)

1. Robert M, Maghami E, Kandeel F, et al.: The role of positron emission tomography scanning in patients with radioactive iodine scan-negative, recurrent differentiated thyroid cancer. Am Surg 2007;73:1052-1056. (Pubitemid 351396566)
2. Mittendorf EA, Wang X, Perrier ND, et al.: Followup of patients with papillary thyroid cancer: In search of the optimal algorithm. J Am Coll Surg 2007;205:239-247.
3. Nguyen VP, Chen SH, Trinh J, et al.: Differential response of lymphatic, venous and arterial endothelial cells to angiopoietin-1 and angiopoietin-2. BMC Cell Biol 2007;8:10.
4. Lewis CE, Hughes R: Inflammation and breast cancer. Microenvironmental factors regulating macrophage function in breast tumours: Hypoxia and angiopoietin-2. Breast Cancer Res 2007;9:209.
5. Park JH, Park KJ, Kim YS, et al.: Serum angiopoietin-2 as a clinical marker for lung cancer. Chest 2007;132:200-206.
6. Yalcin M, Dyskin E, Lansing L, et al.: Tetraiodothyroacetic acid (tetrac) and nanoparticulate tetrac arrest growth of medullary carcinoma of the thyroid. J Clin Endocrinol Metab 2010;95:1972-1980.
7. Wray CJ, Rilo HL, Ahmad SA: Colon cancer angiogenesis and antiangiogenic therapy. Expert Opin Invest Drugs 2004;13:631-641. (Pubitemid 38868053)
8. Lin JD: Papillary thyroid carcinoma with lymph node metastases. Growth Factors 2007;25:41-49.
9. Yonemura Y, Endo Y, Fujita H, et al.: Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res 1999;5:1823-1829. (Pubitemid 29334464)
10. White JD, Hewett PW, Kosuge D, et al.: Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. Cancer Res 2002;62:1669-1675. (Pubitemid 34408487)
11. Rafii S: Circulating endothelial precursors: Mystery, reality, and promise. J Clin Invest 2000;105:17-19.
12. Loges S, Clausen H, Reichelt U, et al.: Determination of microvessel density by quantitative real-time PCR in esophageal cancer: Correlation with histologic methods, angiogenic growth factor expression, and lymph node metastasis. Clin Cancer Res 2007;13:76-80. (Pubitemid 46121855)
13. Sobin LH, Wittekind C, editors. TNM Classification of malignant tumors (UICC). New York: Wiley-Liss; 2002. pp. 52-56.
14. Halloush RA, Akpolat I, Jim Zhai Q, et al.: Comparison of ProEx C with p16INK4a and Ki-67 immunohistochemical staining of cell blocks prepared from residual liquid-based cervicovaginal material: A pilot study. Cancer 2008;114:474-480.
15. Zhang DD, Zhou XH, Freeman DH, et al.: A non-parametric method for the comparison of partial areas under ROC curves and its application to large health care data sets. Stat Med 2002;21:701-715.
16. Mitsutake N, Namba H, Takahara K, et al.: Tie-2 and angiopoietin-1 expression in human thyroid tumors. Thyroid 2002;12:95-98.
17. Bunone G, Vigneri P, Mariani L, et al.: Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am J Pathol 1999;155:1967-1976.
18. Kebebew E, Peng M, Reiff E, et al.: Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms. Surgery 2005;38:1102-1109.
19. Wang JF, Milosveski V, Schramek C, et al.: Presence and possible role of vascular endothelial growth factor in thyroid cell growth and function. J Endocrinol 1998;157:5-12. (Pubitemid 28177487)
20. Itoh A, Iwase K, Jimbo S, et al.: Expression of vascular endothelial growth factor and presence of angiovascular cells in tissues from different thyroid disorders. World J Surg 2010;34:242-248.
21. de Araujo-Filho VJ, Alves VA, de Castro IV, et al.: Vascular endothelial growth factor expression in invasive papillary thyroid carcinoma. Thyroid 2009;19:1233-1237.
22. Soh EY, Duh QY, Sobhi SA, et al.: Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid. J Clin Endocrinol Metab 1997;82:3741-3747. (Pubitemid 27509365)
23. Tanaka K, Sonoo H, Kurebayashi J, et al.: Inhibition of infiltration and angiogenesis by thrombospondin-1 in papillary thyroid carcinoma. Clin Cancer Res 2002;8:1125-1131. (Pubitemid 34517649)
24. Niedzwiecki S, Stepien T, Kopeć K, et al.: Angiopoietin 1 (Ang-1), angiopoietin 2 (Ang-2) and Tie-2 (a receptor tyrosine kinase) concentrations in peripheral blood of patients with thyroid cancers. Cytokines 2006;36:291-295. (Pubitemid 46529482)
25. Hung CJ, Ginzinger DG, Zarnegar R, et al.: Expression of vascular endothelial growth factor-C in benign and malignant thyroid tumors. J Clin Endocrinol Metab 2003;88:3694-3699. (Pubitemid 37034516)
26. Nakamura Y, Yasuoka H, Zuo H, et al.: Nitric oxide in papillary thyroid carcinoma: Induction of vascular endothelial growth factor D and correlation with lymph node metastasis. J Clin Endocrinol Metab 2006;91:1582-1585.
27. Akslen LA, Livolsi VA: Increased angiogenesis in papillary thyroid carcinoma but lack of prognostic importance. Hum Pathol 2000;31:439-442. (Pubitemid 30262865)
28. Bal N, Kocer NE, Ertorer ME, et al.: Maspin, E-selectin, and Pselectin expressions in papillary thyroid carcinomas and their correlation with prognostic parameters. Pathol Res Pract 2008;204:743-750.